Neuronetics (STIM) Preferred Stock Liabilities (2017 - 2018)
Neuronetics' (STIM) quarterly Preferred Stock Liabilities came in at $187.1 million in Q2 2018, little changed on a QoQ basis from $187.1 million in Q1 2018.
Neuronetics (STIM) Preferred Stock Liabilities (2017 - 2018) Analysis & Trends
Neuronetics (STIM) has 2 years of Preferred Stock Liabilities data on file, last reported at $187.1 million in Q2 2018.
- On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $187.1 million in Q2 2018; TTM through Jun 2018 was $187.1 million, a N/A change from a year earlier, with the FY2017 full-year figure at $187.1 million, up 8.6% from the prior year.
- Preferred Stock Liabilities for Q2 2018 stood at $187.1 million, roughly flat from $187.1 million in the prior quarter.
- Over the last five years, Preferred Stock Liabilities for STIM reached as high as $187.1 million in Q4 2017 and fell as low as $187.1 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Neuronetics | 126.30 Mn | 120.30 Mn | 16.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 187.14 Mn |
| Mar 31, 2018 | 187.14 Mn |
| Dec 31, 2017 | 187.14 Mn |